Outcomes and clinical predictors of extracorporeal shock wave therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome: a prospective randomized double-blind placebo-controlled clinical trial

被引：0
|
作者：
Ahmed M. Sakr
Amr M. Fawzi
Mostafa Kamel
Maged M. Ali
机构：
[1] Zagazig University,Urology Department, Faculty of Medicine
来源：
Prostate Cancer and Prostatic Diseases | 2022年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：93 / 99
页数：6
相关论文
共 50 条
  • [1] Outcomes and clinical predictors of extracorporeal shock wave therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome: a prospective randomized double-blind placebo-controlled clinical trial
    Sakr, Ahmed M.
    Fawzi, Amr M.
    Kamel, Mostafa
    Ali, Maged M.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (01) : 93 - 99
  • [2] Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome:: A prospective, randomized, double-blind, placebo-controlled, pilot study
    Mehik, A
    Alas, P
    Nickel, JC
    Sarpola, A
    Helström, PJ
    [J]. UROLOGY, 2003, 62 (03) : 425 - 429
  • [3] Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double-blind placebo controlled clinical trial
    Ahmed M. Tawfik
    Mohammed H. Radwan
    Mohammed Abdulmonem
    Mohammed Abo-Elenen
    Samir A. Elgamal
    Mohammed O. Aboufarha
    [J]. World Journal of Urology, 2022, 40 : 2505 - 2511
  • [4] Extracorporeal Shock Wave Therapy for the Treatment of Chronic Pelvic Pain Syndrome in Males: A Randomised, Double-Blind, Placebo-Controlled Study
    Zimmermann, Reinhold
    Cumpanas, Alin
    Miclea, Florin
    Janetschek, Guenter
    [J]. EUROPEAN UROLOGY, 2009, 56 (03) : 418 - 424
  • [5] Comment on "Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double-blind placebo controlled clinical trial"
    Lao, Yongfeng
    Bai, Yanan
    Wang, Yanan
    Dong, Zhilong
    [J]. WORLD JOURNAL OF UROLOGY, 2022, 40 (10) : 2585 - 2586
  • [6] Correction to: Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double-blind placebo controlled clinical trial
    Ahmed M. Tawfik
    Mohammed H. Radwan
    Mohammed Abdulmonem
    Mohammed Abo-Elenen
    Samir A. Elgamal
    Mohammed O. Aboufarha
    [J]. World Journal of Urology, 2022, 40 : 2513 - 2514
  • [7] Efficacy of Low-Intensity Extracorporeal Shock Wave Therapy for the Treatment of Chronic Pelvic Pain Syndrome IIIb: A Prospective-Randomized, Double-Blind, Placebo-Controlled Study
    Kim, Kang Sup
    Choi, Yong Sun
    Bae, Woong Jin
    Cho, Hyuk Jin
    Ha, U-Syn
    Hong, Sung-Hoo
    Lee, Ji Youl
    Ahn, Sun Tae
    Moon, Du Geon
    Kim, Sae Woong
    [J]. WORLD JOURNAL OF MENS HEALTH, 2022, 40 (03): : 473 - 480
  • [8] Comment on “Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double‑blind placebo controlled clinical trial”
    Yongfeng Lao
    Yanan Bai
    Yanan Wang
    Zhilong Dong
    [J]. World Journal of Urology, 2022, 40 : 2585 - 2586
  • [9] Clinical Efficacy of Multi-Focal Low-Intensity Extracorporeal Shockwave Therapy in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Prospective-Randomized, Double Blind, Placebo-Controlled Study
    Kim, Kang Sup
    Choi, Yong Sun
    Bae, Woong Jin
    Cho, Hyuk Jin
    Ha, U-Syn
    Hong, Sung-Hoo
    Lee, Ji Youl
    Han, Chang Hee
    Kim, Sae Woong
    [J]. WORLD JOURNAL OF MENS HEALTH, 2022, 40 (04): : 678 - 685
  • [10] A First Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Extracorporeal Shock Wave Therapy for the Treatment of Peyronie's Disease
    Palmieri, Alessandro
    Imbimbo, Ciro
    Longo, Nicola
    Fusco, Ferdinando
    Verze, Paolo
    Mangiapia, Francesco
    Creta, Massimiliano
    Mirone, Vincenzo
    [J]. EUROPEAN UROLOGY, 2009, 56 (02) : 363 - 369
12345